Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.37)
# 4,034
Out of 4,761 analysts
22
Total ratings
26.67%
Success rate
-27.46%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $72 → $68 | $32.62 | +108.46% | 2 | Oct 21, 2024 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.30 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $1.82 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $3.13 | +1,401.60% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $49 → $33 | $0.31 | +10,541.73% | 2 | Mar 28, 2023 | |
| ZYXI Zynex | Maintains: Buy | $27 → $28 | $7.19 | +289.43% | 1 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.62 | +5,455.56% | 1 | Aug 4, 2022 | |
| ECOR electroCore | Initiates: Buy | $45 | $17.67 | +154.67% | 1 | Jul 27, 2021 | |
| HROW Harrow | Initiates: Buy | $14 | $28.95 | -50.78% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.68 | +316.67% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $6.30 | +725.40% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11,025 | $4.35 | +253,348.28% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $5.42 | +29.15% | 1 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $6.75 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $61.13 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Oct 21, 2024
Maintains: Neutral
Price Target: $72 → $68
Current: $32.62
Upside: +108.46%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.30
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.82
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $3.13
Upside: +1,401.60%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $49 → $33
Current: $0.31
Upside: +10,541.73%
Zynex
Mar 28, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $7.19
Upside: +289.43%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.62
Upside: +5,455.56%
electroCore
Jul 27, 2021
Initiates: Buy
Price Target: $45
Current: $17.67
Upside: +154.67%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $28.95
Upside: -50.78%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.68
Upside: +316.67%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $6.30
Upside: +725.40%
Jun 26, 2020
Initiates: Buy
Price Target: $11,025
Current: $4.35
Upside: +253,348.28%
Sep 25, 2017
Initiates: Buy
Price Target: $7
Current: $5.42
Upside: +29.15%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $6.75
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $61.13
Upside: -